Open Access

Even though artificial intelligence and machine learning have demonstrated remarkable performances in medical image computing, their accountability and transparency level must be improved to transfer this success into clinical practice. The reliability of machine learning decisions must be explained and interpreted, especially for supporting the medical diagnosis.For this task, the deep learning techniques’ black-box nature must somehow be lightened up to clarify its promising results. Hence, we aim to investigate the impact of the ResNet-50 deep convolutional design for Barrett’s esophagus and adenocarcinoma classification. For such a task, and aiming at proposing a two-step learning technique, the output of each convolutional layer that composes the ResNet-50 architecture was trained and classified for further definition of layers that would provide more impact in the architecture. We showed that local information and high-dimensional features are essential to improve the classification for our task. Besides, we observed a significant improvement when the most discriminative layers expressed more impact in the training and classification of ResNet-50 for Barrett’s esophagus and adenocarcinoma classification, demonstrating that both human knowledge and computational processing may influence the correct learning of such a problem.

Aims Recent evidence suggests the possibility of intraprocedural phase recognition in surgical operations as well as endoscopic interventions such as peroral endoscopic myotomy and endoscopic submucosal dissection (ESD) by AI-algorithms. The intricate measurement of intraprocedural phase distribution may deepen the understanding of the procedure. Furthermore, real-time quality assessment as well as automation of reporting may become possible. Therefore, we aimed to develop an AI-algorithm for intraprocedural phase recognition during ESD. Methods A training dataset of 364385 single images from 9 full-length ESD videos was compiled. Each frame was classified into one procedural phase. Phases included scope manipulation, marking, injection, application of electrical current and bleeding. Allocation of each frame was only possible to one category. This training dataset was used to train a Video Swin transformer to recognize the phases. Temporal information was included via logarithmic frame sampling. Validation was performed using two separate ESD videos with 29801 single frames. Results The validation yielded sensitivities of 97.81%, 97.83%, 95.53%, 85.01% and 87.55% for scope manipulation, marking, injection, electric application and bleeding, respectively. Specificities of 77.78%, 90.91%, 95.91%, 93.65% and 84.76% were measured for the same parameters. Conclusions The developed algorithm was able to classify full-length ESD videos on a frame-by-frame basis into the predefined classes with high sensitivities and specificities. Future research will aim at the development of quality metrics based on single-operator phase distribution.

Aims Artificial Intelligence (AI) systems in gastrointestinal endoscopy are narrow because they are trained to solve only one specific task. Unlike Narrow-AI, general AI systems may be able to solve multiple and unrelated tasks. We aimed to understand whether an AI system trained to detect, characterize, and segment early Barrett’s neoplasia (Barrett’s AI) is only capable of detecting this pathology or can also detect and segment other diseases like early squamous cell cancer (SCC). Methods 120 white light (WL) and narrow-band endoscopic images (NBI) from 60 patients (1 WL and 1 NBI image per patient) were extracted from the endoscopic database of the University Hospital Augsburg. Images were annotated by three expert endoscopists with extensive experience in the diagnosis and endoscopic resection of early esophageal neoplasias. An AI system based on DeepLabV3+architecture dedicated to early Barrett’s neoplasia was tested on these images. The AI system was neither trained with SCC images nor had it seen the test images prior to evaluation. The overlap between the three expert annotations („expert-agreement“) was the ground truth for evaluating AI performance. Results Barrett’s AI detected early SCC with a mean intersection over reference (IoR) of 92% when at least 1 pixel of the AI prediction overlapped with the expert-agreement. When the threshold was increased to 5%, 10%, and 20% overlap with the expert-agreement, the IoR was 88%, 85% and 82%, respectively. The mean Intersection Over Union (IoU) – a metric according to segmentation quality between the AI prediction and the expert-agreement – was 0.45. The mean expert IoU as a measure of agreement between the three experts was 0.60. Conclusions In the context of this pilot study, the predictions of SCC by a Barrett’s dedicated AI showed some overlap to the expert-agreement. Therefore, features learned from Barrett’s cancer-related training might be helpful also for SCC prediction. Our results allow different possible explanations. On the one hand, some Barrett’s cancer features generalize toward the related task of assessing early SCC. On the other hand, the Barrett’s AI is less specific to Barrett’s cancer than a general predictor of pathological tissue. However, we expect to enhance the detection quality significantly by extending the training to SCC-specific data. The insight of this study opens the way towards a transfer learning approach for more efficient training of AI to solve tasks in other domains.

Background and study aims To evaluate the effect of an AI-based clinical decision support system (AI) on the performance and diagnostic confidence of endoscopists during the assessment of Barrett's esophagus (BE). Patients and Methods Ninety-six standardized endoscopy videos were assessed by 22 endoscopists from 12 different centers with varying degrees of BE experience. The assessment was randomized into two video sets: Group A (review first without AI and second with AI) and group B (review first with AI and second without AI). Endoscopists were required to evaluate each video for the presence of Barrett's esophagus-related neoplasia (BERN) and then decide on a spot for a targeted biopsy. After the second assessment, they were allowed to change their clinical decision and confidence level. Results AI had a standalone sensitivity, specificity, and accuracy of 92.2%, 68.9%, and 81.6%, respectively. Without AI, BE experts had an overall sensitivity, specificity, and accuracy of 83.3%, 58.1 and 71.5%, respectively. With AI, BE nonexperts showed a significant improvement in sensitivity and specificity when videos were assessed a second time with AI (sensitivity 69.7% (95% CI, 65.2% - 74.2%) to 78.0% (95% CI, 74.0% - 82.0%); specificity 67.3% (95% CI, 62.5% - 72.2%) to 72.7% (95 CI, 68.2% - 77.3%). In addition, the diagnostic confidence of BE nonexperts improved significantly with AI. Conclusion BE nonexperts benefitted significantly from the additional AI. BE experts and nonexperts remained below the standalone performance of AI, suggesting that there may be other factors influencing endoscopists to follow or discard AI advice.

Limitations in computer-assisted diagnosis include lack of labeled data and inability to model the relation between what experts see and what computers learn. Even though artificial intelligence and machine learning have demonstrated remarkable performances in medical image computing, their accountability and transparency level must be improved to transfer this success into clinical practice. The reliability of machine learning decisions must be explained and interpreted, especially for supporting the medical diagnosis. While deep learning techniques are broad so that unseen information might help learn patterns of interest, human insights to describe objects of interest help in decision-making. This paper proposes a novel approach, DeepCraftFuse, to address the challenge of combining information provided by deep networks with visual-based features to significantly enhance the correct identification of cancerous tissues in patients affected with Barrett’s esophagus (BE). We demonstrate that DeepCraftFuse outperforms state-of-the-art techniques on private and public datasets, reaching results of around 95% when distinguishing patients affected by BE that is either positive or negative to esophageal cancer.